Alpha Teknova (TKNO) Competitors $4.41 -0.11 (-2.41%) As of 12:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TKNO vs. CRMD, TSHA, IMNM, AMLX, IOVA, PHAT, URGN, TRVI, DNTH, and AVBPShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include CorMedix (CRMD), Taysha Gene Therapies (TSHA), Immunome (IMNM), Amylyx Pharmaceuticals (AMLX), Iovance Biotherapeutics (IOVA), Phathom Pharmaceuticals (PHAT), Urogen Pharma (URGN), Trevi Therapeutics (TRVI), Dianthus Therapeutics (DNTH), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Its Competitors CorMedix Taysha Gene Therapies Immunome Amylyx Pharmaceuticals Iovance Biotherapeutics Phathom Pharmaceuticals Urogen Pharma Trevi Therapeutics Dianthus Therapeutics ArriVent BioPharma Alpha Teknova (NASDAQ:TKNO) and CorMedix (NASDAQ:CRMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment. Does the media prefer TKNO or CRMD? In the previous week, CorMedix had 21 more articles in the media than Alpha Teknova. MarketBeat recorded 22 mentions for CorMedix and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.91 beat CorMedix's score of 0.45 indicating that Alpha Teknova is being referred to more favorably in the media. Company Overall Sentiment Alpha Teknova Very Positive CorMedix Neutral Which has more volatility & risk, TKNO or CRMD? Alpha Teknova has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, CorMedix has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Do institutionals and insiders have more ownership in TKNO or CRMD? 13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 34.2% of CorMedix shares are owned by institutional investors. 12.5% of Alpha Teknova shares are owned by company insiders. Comparatively, 5.3% of CorMedix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable earnings & valuation, TKNO or CRMD? CorMedix has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Teknova$37.74M6.25-$26.75M-$0.42-10.50CorMedix$43.47M19.61-$17.93M$0.7515.23 Is TKNO or CRMD more profitable? CorMedix has a net margin of 42.11% compared to Alpha Teknova's net margin of -55.24%. CorMedix's return on equity of 42.73% beat Alpha Teknova's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Teknova-55.24% -26.51% -18.40% CorMedix 42.11%42.73%34.19% Do analysts rate TKNO or CRMD? Alpha Teknova currently has a consensus target price of $10.00, indicating a potential upside of 126.71%. CorMedix has a consensus target price of $18.00, indicating a potential upside of 57.62%. Given Alpha Teknova's stronger consensus rating and higher probable upside, research analysts clearly believe Alpha Teknova is more favorable than CorMedix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50CorMedix 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryCorMedix beats Alpha Teknova on 12 of the 16 factors compared between the two stocks. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$236.25M$3.15B$5.76B$10.26BDividend YieldN/A2.36%5.88%4.63%P/E Ratio-10.5121.4076.8426.62Price / Sales6.25459.04528.69125.58Price / CashN/A45.4037.1760.46Price / Book2.859.6913.856.32Net Income-$26.75M-$53.02M$3.29B$271.01M7 Day Performance11.39%1.76%1.49%2.75%1 Month Performance-5.95%5.38%5.21%7.15%1 Year Performance-7.53%9.72%83.43%28.02% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova2.8132 of 5 stars$4.41-2.4%$10.00+126.7%+2.7%$236.25M$37.74M-10.51240CRMDCorMedix3.9208 of 5 stars$12.75+2.8%$17.33+35.9%+64.2%$925.65M$43.47M17.0030Insider TradeTSHATaysha Gene Therapies2.2926 of 5 stars$3.24-3.6%$8.29+155.7%+30.9%$916.59M$8.33M-9.53180IMNMImmunome2.3646 of 5 stars$9.40-10.6%$22.89+143.5%-42.4%$915.71M$9.04M-3.0540Positive NewsAMLXAmylyx Pharmaceuticals2.8154 of 5 stars$10.44+2.4%$12.25+17.3%+351.3%$909.51M$87.37M-4.18200Analyst ForecastIOVAIovance Biotherapeutics4.3347 of 5 stars$2.38-4.4%$11.90+400.0%-76.6%$901.02M$164.07M-1.93500PHATPhathom Pharmaceuticals2.5246 of 5 stars$12.43+0.7%$17.50+40.8%-41.9%$875.45M$55.25M-2.63110News CoverageURGNUrogen Pharma4.0908 of 5 stars$21.42+13.5%$32.00+49.4%+36.9%$873.47M$90.40M-6.45200Positive NewsHigh Trading VolumeTRVITrevi Therapeutics2.8296 of 5 stars$7.60+8.4%$21.75+186.2%+126.8%$853.66MN/A-18.0920Positive NewsHigh Trading VolumeDNTHDianthus Therapeutics3.1161 of 5 stars$31.80+20.0%$54.00+69.8%+41.8%$852.99M$6.24M-9.7880Gap UpHigh Trading VolumeAVBPArriVent BioPharma2.0058 of 5 stars$20.21+0.1%$39.14+93.7%-25.8%$819.09MN/A-5.0340Positive News Related Companies and Tools Related Companies CRMD Competitors TSHA Competitors IMNM Competitors AMLX Competitors IOVA Competitors PHAT Competitors URGN Competitors TRVI Competitors DNTH Competitors AVBP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TKNO) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
